Çмú ³í¹® - ¿¹¹æ ¹× ¹é½Å
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (The Lancet Infectious Disease, Published: November 17, 2020)
- Next ÁÖ¿ä ¹é½Å ÀÓ»ó ³í¹®µé(Updated at 2020.1.29)
- Previous Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (The Lancet Infectious Disease, Published: November 17, 2020)